PULSE BIOSCIENCES, INC.

Developing nsPFA bioelectric tech for precise, non-thermal tissue ablation in cardiology.

PLSE | NDAQ

Overview

Corporate Details

ISIN(s):: US74587B1017
LEI:
Country:: United States of America
Address:: 3957 POINT EDEN WAY, 94545 HAYWARD
Website:: https://www.pulsebiosciences.com/
Sector:: Manufacturing
Industry:: Manufacture of medical and dental instruments and supplies

Description

Pulse Biosciences, Inc. is a bioelectric medicine company developing a proprietary therapeutic platform based on Nanosecond Pulsed Field Ablation (nsPFA) technology. This novel, nonthermal energy modality is designed to precisely ablate cellular tissue while sparing adjacent noncellular structures. The company's primary focus is on advancing treatments in cardiology, particularly for atrial fibrillation, through its investigational CellFX® nsPFA™ 360 Cardiac Catheter and Cardiac Clamp. Pulse Biosciences is also expanding its nsPFA technology into other medical applications, including the development of a percutaneous electrode for the treatment of benign thyroid nodules. The company is actively advancing its product pipeline through clinical studies and regulatory submissions to establish nsPFA as a new standard of care in various medical procedures.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all PULSE BIOSCIENCES, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PULSE BIOSCIENCES, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for PULSE BIOSCIENCES, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
AtriCure, Inc. Develops surgical devices for Afib, LAA management, and non-opioid pain relief.	United States of America	ATRC
AuBEX CORPORATION High-precision manufacturer of nibs for stationery, cosmetics, and medical infusion technology.	Japan	3583
Audientes A/S Develops smart, self-fitting, and affordable hearing aids for adults with hearing loss.	Denmark	AUDNTS
AVANOS MEDICAL, INC. Medical devices for non-opioid pain management and chronic care enteral feeding solutions.	United States of America	AVNS
AVITA Medical, Inc. Regenerative solutions for burns and wounds using a patient's own Spray-On Skin™ Cells.	United States of America	RCEL
Axogen, Inc. Develops surgical solutions, including nerve allografts, for peripheral nerve repair and regeneration.	United States of America	AXGN
Bactiguard Holding Licenses a patented coating to MedTech partners to prevent medical device infections.	Sweden	BACTI
Bausch & Lomb Corp A global eye health company offering contact lenses, pharmaceuticals, and surgical devices for all.	United States of America	BLCO
BAXTER INTERNATIONAL INC Provides life-sustaining products for IV, surgical, and renal care in hospitals and homes.	United States of America	BAX
BBS-Bioactive Bone Substitutes Oyj Developed a bioactive bone graft substitute for orthopedic surgery before filing for bankruptcy.	Finland	BONE